POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME

POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME was reported 284 times

POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 5-alpha Reductase Inhibitor [EPC] 279 0.0027
1 Arteriolar Vasodilator [EPC] 10 0.0001
2 Barbiturate [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 2 0.0001
4 Angiotensin Converting Enzyme Inhibitor [EPC] 8 0.0001
5 Phosphodiesterase 5 Inhibitor [EPC] 5 0.0000
6 Aromatase Inhibitor [EPC] 4 0.0000
7 Serotonin Reuptake Inhibitor [EPC] 2 0.0000
8 Methylxanthine [EPC] 1 0.0000
9 Central Nervous System Stimulant [EPC] 1 0.0000
10 Vitamin D [EPC] 1 0.0000
11 Vitamin B12 [EPC] 1 0.0000
12 Vitamin C [EPC] 1 0.0000